- Home
- TRX vs TNYA Comparison
TRX vs TNYA Comparison
Compare TRX & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRX
- TNYA
- Stock Information
- Founded
- TRX 1990
- TNYA 2016
- Country
- TRX Canada
- TNYA United States
- Employees
- TRX N/A
- TNYA N/A
- Industry
- TRX
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- TRX
- TNYA Health Care
- Exchange
- TRX Nasdaq
- TNYA Nasdaq
- Market Cap
- TRX 178.8M
- TNYA 189.1M
- IPO Year
- TRX N/A
- TNYA 2021
- Fundamental
- Price
- TRX $0.62
- TNYA $1.78
- Analyst Decision
- TRX Strong Buy
- TNYA Strong Buy
- Analyst Count
- TRX 1
- TNYA 5
- Target Price
- TRX $1.10
- TNYA $8.60
- AVG Volume (30 Days)
- TRX 1.6M
- TNYA 3.1M
- Earning Date
- TRX 07-15-2025
- TNYA 11-05-2025
- Dividend Yield
- TRX N/A
- TNYA N/A
- EPS Growth
- TRX N/A
- TNYA N/A
- EPS
- TRX N/A
- TNYA N/A
- Revenue
- TRX $47,731,000.00
- TNYA N/A
- Revenue This Year
- TRX $23.64
- TNYA N/A
- Revenue Next Year
- TRX $51.77
- TNYA N/A
- P/E Ratio
- TRX $601.00
- TNYA N/A
- Revenue Growth
- TRX 29.98
- TNYA N/A
- 52 Week Low
- TRX $0.27
- TNYA $0.36
- 52 Week High
- TRX $0.65
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- TRX 72.02
- TNYA 68.30
- Support Level
- TRX $0.57
- TNYA $1.59
- Resistance Level
- TRX $0.65
- TNYA $1.72
- Average True Range (ATR)
- TRX 0.04
- TNYA 0.12
- MACD
- TRX 0.00
- TNYA 0.01
- Stochastic Oscillator
- TRX 81.36
- TNYA 85.00
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.